Interestingly, the co-occurrence of NASH significantly upregulated the gene expression of Il23a, Il1b, Il36g, and Mip2, compared with that in IMQ-treated mice without NASH (Figure 4). The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatohepatitis.